Importantly, these immunological shifts were associated with reduced regulatory T cell infiltration and increased recruitment of CD8+ cytotoxic T cells, suggesting that ApoSQ-CAF CM reshapes the TME to favor anti-tumor immunity and attenuate lung cancer progression. The gene discussed is CD8A; the disease is lung carcinoma.